Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review
Endocrine Connections · 01.11.2025 · 14 (11)
DOI: 10.1530/ec-25-0135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Connections, online erschienen am 21.10.2025. Verfasst von Fabian O Lurquin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Graphical Abstract Abstract Alongside pulmonary and nutritional benefits, highly effective modulator therapies (HEMT) can promote an increase in body fat and raise the prevalence of overweight/obesity, dyslipidemia, and hypertension in patients with cystic fibrosis. These metabolic changes will theoretically elevate cardiovascular risk in a population that has largely been unaffected by such complications until now. A rise in the prevalence of metabolic syndrome among HEMT-treated patients is expected, which has already prompted a review of dietary recommendations. Thus, a distinction must be made between patients with several years of care experience and those, especially younger patients or those with a late diagnosis of cystic fibrosis, who have not been educated on the principle of a high-calorie diet. Whether these metabolic changes will result in a greater incidence of cardiovascular events remains uncertain, underscoring the need to validate predictive risk scores in this context.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
- Endocrinology, Diabetes, Nutrition Pole (EDIN), Institut de recherche expérimentale et clinique, (IREC), UCLouvain, Brussels, Belgium.
- Department of Pneumology, CF Reference Centre, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
- Lung, Nose, Skin Pole (LUNS), Institut de recherche expérimentale et clinique, (IREC), UCLouvain, Brussels, Belgium.
ORCID-Profile: Fabian O Lurquin
Zitieren
APA
Lurquin, F. O., Hermans, M. P., Gohy, S., & Preumont, V. (2025). Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. Endocrine Connections, 14(11). https://doi.org/10.1530/ec-25-0135
Vancouver
Lurquin FO, Hermans MP, Gohy S, Preumont V. Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. Endocrine Connections. 2025;14(11). doi:10.1530/ec-25-0135
BibTeX
@article{Lurquin2025,
author = {Lurquin, Fabian O and Hermans, Michel P and Gohy, Sophie and Preumont, Vanessa},
title = {Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review},
journal = {Endocrine Connections},
year = {2025},
volume = {14},
number = {11},
doi = {10.1530/ec-25-0135}
}
EUVIMED